Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)

NCT00185159 is registered in ClinicalTrials.gov with Sankyo Pharma Gmbh as lead sponsor.

NCT NCT00185159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)
Lead sponsor
Sankyo Pharma Gmbh
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
July 31, 2009
Enrollment
4,449 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, diabetes mellitus, type 2, kidney disease